Use of the Repeatable Battery for the Assessment of Neuropsychological status (RBANS) to investigate group and gender differences in schizophrenia and bipolar disorder

Australian and New Zealand Journal of Psychiatry

Volumn 44, Issue 3, 2010, Pages 220-229

  Gogos, Andrea ^a,b   Joshua, Nicole ^a,b   Rossell, Susan L ^a,c,d,e  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c School of Psychology Psychiatry and Psychological Medicine ^*  (Australia)

^d Department of Biomedical Science   (Australia)

^e ALFRED HOSPITAL   (Australia)

Author keywords

Attention; Bipolar disorder; Cognition; Language; Memory

Indexed keywords

ANTIDEPRESSANT AGENT; CHLORPROMAZINE; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATTENTION; BIPOLAR DISORDER; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPTH PERCEPTION; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; LANGUAGE; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL PATIENT; MENTAL TASK; NEUROPSYCHOLOGICAL TEST; RECALL; REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS; SCHIZOPHRENIA; SCORING SYSTEM; SEX DIFFERENCE; SEX ROLE; SHORT TERM MEMORY; TASK PERFORMANCE;

ADULT; ATTENTION; BIPOLAR DISORDER; CASE-CONTROL STUDIES; COGNITION; FEMALE; HUMANS; LANGUAGE; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX FACTORS; TIME FACTORS;

EID: 77649087890     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.3109/00048670903446882     Document Type: Article

References (57)

1. Gur RC, Ragland JD, Gur RE. Cognitive changes in schizophrenia: a critical look. Int Rev Psychiatry 1997; 9:449-457.
2. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998; 12:426-445.
3. Goldberg TE, Greenberg RD, Griffin SJ et al. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 1993; 162:43-48.
4. Saykin AJ, Shtasel DL, Gur RE et al. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry 1994; 51:124-131.
5. Censits DM, Ragland JD, Gur RC, Gur RE. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr Res 1997; 24:289-298.
6. Loughland CM, Lewin TJ, Carr VJ, Sheedy J, Harris AW. RBANS neuropsychological profiles within schizophrenia samples recruited from non-clinical settings. Schizophr Res 2007; 89:232-242.
7. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res 2004; 72:29-39.
8. Fuller RL, Luck SJ, McMahon RP, Gold JM. Working memory consolidation is abnormally slow in schizophrenia. J Abnorm Psychol 2005; 114:279-290.
9. Silver H, Feldman P, Bilker W, Gur RC. Working memory deficit as a core neuropsychological dysfunction in schizophrenia. Am J Psychiatry 2003; 160:1809-1816.
10. Landro NI, Orbeck AL, Rund BR. Memory functioning in chronic and non-chronic schizophrenics, affectively disturbed patients and normal controls. Schizophr Res 1993; 10:85-92.
11. Lee J, Park S. Working memory impairments in schizophrenia: a meta-analysis. J Abnorm Psychol 2005; 114:599-611.
12. Cirillo MA, Seidman LJ. Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev 2003; 13:43-77.
13. Tracy JI, Mattson R, King C, Bundick T, Celenza MA, Glosser G. A comparison of memory for verbal and non-verbal material in schizophrenia. Schizophr Res 2001; 50:199-211.
14. Rossell SL, David AS. Are semantic deficits in schizophrenia due to problems with access or storage? Schizophr Res 2006; 82:121-134.
15. Wang Q, Chan R, Sun J et al. Reaction time of the Continuous Performance Test is an endophenotypic marker for schizophrenia: a study of first-episode neuroleptic-naive schizophrenia, their non-psychotic first-degree relatives and healthy population controls. Schizophr Res 2007; 89:293-298.
16. Kurtz MM, Ragland JD, Bilker W, Gur RC, Gur RE. Comparison of the continuous performance test with and without working memory demands in healthy controls and patients with schizophrenia. Schizophr Res 2001; 48:307-316.
17. Laws KR. A meta-analytic review of Wisconsin Card Sort studies in schizophrenia: general intellectual deficit in disguise? Cogn Neuropsychiatry 1999; 4:1-30.
18. Joshua N, Gogos A, Rossell SL. Executive functioning in schizophrenia: a thorough examination of performance on the Hayling Sentence Completion test compared to psychiatric and non-psychiatric controls. Schizophr Res 2009; 114:84-90.
19. Rossell SL. Category fluency performance in patients with schizophrenia and bipolar disorder: the influence of affective categories. Schizophr Res 2006; 82:135-138.
20. Randolph C. Repeatable Battery for the Assessment of Neuropsy-chological Status (RBANS). Florida: Psychcorp, 1998.
21. Randolph C, Tierney MC, Mohr E, Chase TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 1998; 20:310-319.
22. Gold JM, Queern C, Iannone VN, Buchanan RW. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity. Am J Psychiatry 1999; 156:1944-1950.
23. Dickerson F, Boronow JJ, Stallings C, Origoni AE, Cole SK, Yolken RH. Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status. Psychiatry Res 2004; 129:45-53.
24. Hobart MP, Goldberg R, Bartko JJ, Gold JM. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons. Am J Psychiatry 1999; 156:1951-1957.
25. Wilk CM, Gold JM, Bartko JJ et al. Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia. Am J Psychiatry 2002; 159:838-844.
26. Wilk CM, Gold JM, Humber K, Dickerson F, Fenton WS, Buchanan RW. Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status. Schizophr Res 2004; 70:175-186.
27. Holzer L, Chinet L, Jaugey L et al. Detection of cognitive impairment with the Repeatable Battery for the Assessment of Neu-ropsychological Status (RBANS) in adolescents with psychotic symptomatology. Schizophr Res 2007; 95:48-53.
28. Chouinard S, Stip E, Poulin J et al. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits. Curr Med Res Opin 2007; 23:575-583.
29. Schubert MH, Young KA, Hicks PB. Galantamine improves cognition in schizophrenic patients stabilized on risperidone. Biol Psychiatry 2006; 60:530-533.
30. Delle Chiaie R, Salviati M, Fiorentini S, Biondi M. Add-on mirta-zapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine. Exp Clin Psychopharmacol 2007; 15:563-568.
31. Weber B. RBANS has reasonable test-retest reliability in schizophrenia. Evid Based Ment Health 2003; 6:22.
32. Goldstein JM, Seidman LJ, Goodman JM et al. Are there sex differences in neuropsychological functions among patients with schizophrenia? Am J Psychiatry 1998; 155:1358-1364.
33. Leung A, Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 2000; 401:3-38.
34. Hambrecht M, Maurer K, Hafner H. Gender differences in schizophrenia in three cultures. Results of the WHO collaborative study on psychiatric disability. Soc Psychiatry Psychiatr Epidemiol 1992; 27:117-121.
35. Häfner H, Riecher-Rossler A, An Der Heiden W, Maurer K, Fatkenheuer B, Loffler W. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 1993; 23:925-940.
36. Castle DJ, Murray RM. The epidemiology of late-onset schizophrenia. Schizophr Bull 1993; 19:691-700.
37. Häfner H, an der Heiden W, Behrens S et al. Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophr Bull 1998; 24:99-113.
38. Castle DJ, Abel K, Takei N, Murray RM. Gender differences in schizophrenia: hormonal effect or subtypes? Schizophr Bull 1995; 21:1-12.
39. Seeman MV, Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull 1990; 16:185-194.
40. Szymanski S, Lieberman JA, Alvir JM et al. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry 1995; 152:698-703.
41. Beatty WW, Mold JW, Gontkovsky ST. RBANS performance: influences of sex and education. J Clin Exp Neuropsychol 2003; 25:1065-1069.
42. Maylor EA, Reimers S, Choi J, Collaer ML, Peters M, Silverman I. Gender and sexual orientation differences in cognition across adulthood: age is kinder to women than to men regardless of sexual orientation. Arch Sex Behav 2007; 36:235-249.
43. Sota TL, Heinrichs RW. Sex differences in verbal memory in schizophrenia patients treated with 'typical' neuroleptics. Schizophr Res 2003; 62:175-182.
44. Halari R, Mehrotra R, Sharma T, Ng V, Kumari V. Cognitive impairment but preservation of sexual dimorphism in cognitive abilities in chronic schizophrenia. Psychiatry Res 2006; 141:129-139.
45. Lewine RR, Walker EF, Shurett R, Caudle J, Haden C. Sex differences in neuropsychological functioning among schizophrenic patients. Am J Psychiatry 1996; 153:1178-1184.
46. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 2004; 71:405-416.
47. Robinson LJ, Thompson JM, Gallagher P et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006; 93:105-115.
48. Barrett SL, Kelly C, Bell R, King DJ. Gender influences the detection of spatial working memory deficits in bipolar disorder. Bipolar Disord 2008; 10:647-654.
49. Dickerson FB, Sommerville J, Origoni AE, Ringel NB, Parente F. Outpatients with schizophrenia and bipolar I disorder: do they differ in their cognitive and social functioning? Psychiatry Res 2001; 102:21-27.
50. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press, 1996.
51. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-276.
52. Nelson HE, Willison J. The National Adult Reading Test manual. Windsor: NFER, 1991.
53. Krabbendam L, Arts B, van Os J, Aleman A. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr Res 2005; 80:137-149.
54. Gogos A, van den Buuse M, Rossell S. Gender differences in pre-pulse inhibition (PPI) in bipolar disorder: men have reduced PPI, women have increased PPI. Int J Neuropsychopharmacol 2009; 12:1249-1259.
55. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the 'right stuff'? Schizophr Bull 2000; 26:119-136.
56. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153:321-330.
57. Medalia A, Lim R. Treatment of cognitive dysfunction in psychiatric disorders. J Psychiatr Pract 2004; 10:17-25.